Skip to content

Evaluation of rise in blood glucose and insulin after consumption of a marketed sugar product

Evaluation of Glycemic Index and Insulin Index of a marketed sugar product - GLIPAR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030248
Enrollment
30
Registered
2021-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Herbal blended sugar product: A new blended sugar with medicinal herbs that are appropriate for all individuals irrespective of their health status. It is an FSSAI approved food produc

Sponsors

EID PARRY INDIA LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Apparently healthy volunteers: 1. South Indian ethnicity (Participants residing in one of the 5 south Indian states for at least 3 generations and speaking the native south Indian language) 2. Age group of 25-45 years 3. BMI of 22-25 kg/m2 4. Must be willing to comply with all study requirement 5. Participants should agree to avoid any kind of herbal formulations during the study period

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. History of cardiovascular disease, Type 2 Diabetes mellitus, pulmonary, hepatic and renal problems 2. History of any long term medication 3. Known allergy to herbal products 4. Chronic smokers and alcoholics 5. Elevated blood pressure on the day of testing (Two consecutive BP readings greater than or equal to 140/90 mm/hg ) 6. Pregnant or lactating women 7. Students

Design outcomes

Primary

MeasureTime frame
Glycemic Index will be assessed on the same day over a set of 7 time points (baseline and 6 time points) for 5 visits over a period of 1 month.Timepoint: Glycemic Index will be assessed on the same day over a set of 7 time points (baseline and 6 time points) for 5 visits over a period of 1 month.

Secondary

MeasureTime frame
Insulin Index will be assessed on the same day over a set of 7 time points (baseline and 6 time points) for 4 visits over a period of 1 month.Timepoint: Insulin Index will be assessed on the same day over a set of 7 time points (baseline and 6 time points) for 4 visits over a period of 1 month.

Countries

India

Contacts

Public ContactDr S Akila

JIPMER

drjayanthi2008@gmail.com9442395291

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026